News

Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viruses, ...
Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat ...
JelloX Biotech Inc., a Taiwan-based startup at the forefront of cancer pathology, announced the preliminary results of a research collabora ...
Vijay Varma, Fatima Sana Shaikh’s romantic movie Ul Jalool Ishq gets a new title; duo's chemistry shines in first poster Jaat vs Gadar 2 Day 7 Box Office: Comparing theatrical run of Sunny Deol’s ...
Frazier Life Sciences (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointment of Aditya Kohli, Ph.D., to Partner. Since joining FLS in 2016, Dr. Kohli ...
The 2025 New York International Auto Show (NYIAS) will celebrate a milestone when it kicks off on Friday - its 125th ...
With tariffs pushing manufacturing home to the U.S., Pitchbook warns of reduced M&A activity and venture capital funding.
With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...
Two new studies suggest that Parkinson's disease can potentially be treated with stem cells placed in a patient's brain.
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that it will report financial results for the first quarter ending March 31, 2025 on Thursday, May 1, 2025, ...
Dr. Daniel Chen, at the University of Oxford and Chief Scientist at biotech startup Oxperial BioHealth, revealed their major ...
In a remarkable fusion of nature and science, China has ushered in a new era of textile technology with genetically modified ...